# Effect of Bitopertin on the Liver and on Levels of Protoporphyrin IX in Bile, Blood, Liver, and Stool in Patients With Erythropoietic Protoporphyria/X-linked Protoporphyria and Increased Liver Stiffness and/or Liver Enzymes at Baseline

> **NCT07123363** · PHASE1 · WITHDRAWN · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Protoporphyria

## Interventions

- **DRUG:** bitopertin

## Key facts

- **NCT ID:** NCT07123363
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-01
- **Primary completion:** 2035-12
- **Final completion:** 2035-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** department leadership decided not to proceed with study
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07123363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07123363, "Effect of Bitopertin on the Liver and on Levels of Protoporphyrin IX in Bile, Blood, Liver, and Stool in Patients With Erythropoietic Protoporphyria/X-linked Protoporphyria and Increased Liver Stiffness and/or Liver Enzymes at Baseline". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT07123363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*